Investor Values Nobel Biocare 30 to 50 Percent Higher: Barrons
NEW YORK (Reuters) - Nobel Biocare Holding AG <NOBN.VX> may
be worth 30 percent to 50 percent more than its current share
price according to a Barron’s April 7 story, citing a
investor’s estimated value for the company.